Login / Signup

Biologics targeting type I interferons in SLE: A meta-analysis and systematic review of randomised controlled trials.

Jeffery Wei Heng KohCheng Han NgSen Hee Tay
Published in: Lupus (2020)
This meta-analysis substantiates IFNAR as a therapeutic target in SLE. Inhibition of type I IFNs predisposes to herpes zoster and other viral infections.
Keyphrases
  • systematic review
  • systemic lupus erythematosus
  • meta analyses
  • disease activity
  • sars cov
  • rheumatoid arthritis
  • cancer therapy
  • randomized controlled trial
  • drug delivery